Welcome to the Working Group on New TB Drugs Blog
Posted in TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Interview with Dr. Lee Reichman – Part One
This is part one of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.
This Week in TB R&D – July 27, 2010
The route of drug delivery for TB drugs is an interesting one with the usual (and valuable) room for debate about different methods. While the standard mode of delivery for most drugs is oral, there is ongoing discussion as to whether aerosol delivery of TB drugs may be a more suitable route of delivery for treating pulmonary TB.
Women TB Patients Face Bias and Violence
Eight months into her marriage, Rose Joseph (21, name changed) was diagnosed with tuberculosis (TB) in January. Joseph was hospitalised for a week but when she was discharged, her husband asked her to stay at her parents’ place in Malad, saying he and his family had to travel for a wedding. For two weeks, her husband did not call to check on her. When her mother took her to her husband’s home, her mother-in-law said they didn’t want her in the house because she had TB. “My husband wasn’t even ready to face me. My mattress, bedsheets and other belongings had been burned,” said Joseph.
Vienna 2010: Citizen News Service Correspondent Statement on IPT
Citizen News Service correspondent, Bobby Ramakant, reiterates the call from the Stop TB Working Group on TB/HIV to introduce Isoniazid prevention therapy to prevent the progression of latent TB infection to active disease. Effective IPT treatment reduces the development of active TB disease in 40-60% of patients. The content of this post originally appeared in an email sent to the Stop TB Health Dev mailing list.
TAG 2010 Pipeline Report
Treatment Action Group (TAG) recently released their TAG 2010 Pipeline Report, an annual report that explores the progress and overall state of drug development in the fields of HIV, Tuberculosis, and Viral Hepatitis. The report covers the development of drugs, diagnostics, vaccines, immune-based therapies, and preventative technologies in development in each field.
This Week in TB R&D – July 20, 2010
On Friday, July 16th, the fourth annual New England TB Symposium took place at the Broad Institute, in Cambridge, Massachusetts. The symposium was in collaboration with the US-Japan Cooperative Medical Sciences Program: 45th Tuberculosis and Leprosy Research Conference which preceded the symposium at the Broad from July 13-15th.
A brief synopsis of some of the symposium [...]
The Sanatorium Files: Part 4 – DOTS
Connecting the DOTS: Unprecedented Approach to Ensure Compliance. This is the fourth in our series “The Sanatorium Files.” We round out the series with this post on the most recent development in the treatment of TB: an unusual and unprecedented public health program to ensure compliance with the TB drug regimen called directly observed therapy, short course (DOTS).
This Week in TB R&D – 13 July 2010
Last week we highlighted the Xpert® MTB/RIF assay for diagnostic testing. This week, we will briefly describe the GenoType® MTBDRplus assay. The GenoType® MTBDRplus assay uses PCR to amplify biotin-labeled amplicons (single-stranded DNA sequences) of M. tb from sputum.
The Outcasts of Tuberculosis
It may be curable but Tuberculosis (TB) remains a stigma in our country especially for women. Over a lakh Indian women are thrown out of their homes each year because they have TB. NDTV brings you the story of a woman who was deserted by her husband one year after marriage because she was diagnosed with TB. The 21-year-old woman’s only fault was that she was infected with tuberculosis.
Dual Infections Of TB And AIDS Make Each Harder To Treat
Tuberculosis infects nearly ten million people each year and kills nearly two million. It is primarily a lung disease that spreads easily among people with weakened immune systems. Sub-Saharan Africa is still the epicenter of the HIV/AIDS disaster, but it is also becoming the epicenter of tuberculosis.
-
Toppix TB News- Expert says Tuberculosis a neglected disease 30 Jul 2010
- Potential Tuberculostatic Agents: Micelle-Forming Copolymer... 28 Jul 2010
- Center for Health Market Innovations: A Knowledge Database for BoP Markets 28 Jul 2010
- Study Identifies Effective, Inexpensive Test For Tuberculosis In Children 27 Jul 2010
- Randomized Trial in Haiti Shows Benefits of Early Antiretroviral Therapy 27 Jul 2010
